hrcak mascot   Srce   HID

Izvorni znanstveni članak

Helicobacter pylori seroprevalence in coronary artery disease

Mirjana Grozdovska-Naumoska
Vlatko Kotevski
Sonja Trojacanec-Piponska

Puni tekst: engleski, pdf (119 KB) str. 193-196 preuzimanja: 183* citiraj
APA 6th Edition
Grozdovska-Naumoska, M., Kotevski, V. i Trojacanec-Piponska, S. (2007). Helicobacter pylori seroprevalence in coronary artery disease. Biochemia Medica, 17 (2), 193-196. Preuzeto s https://hrcak.srce.hr/18134
MLA 8th Edition
Grozdovska-Naumoska, Mirjana, et al. "Helicobacter pylori seroprevalence in coronary artery disease." Biochemia Medica, vol. 17, br. 2, 2007, str. 193-196. https://hrcak.srce.hr/18134. Citirano 27.01.2021.
Chicago 17th Edition
Grozdovska-Naumoska, Mirjana, Vlatko Kotevski i Sonja Trojacanec-Piponska. "Helicobacter pylori seroprevalence in coronary artery disease." Biochemia Medica 17, br. 2 (2007): 193-196. https://hrcak.srce.hr/18134
Harvard
Grozdovska-Naumoska, M., Kotevski, V., i Trojacanec-Piponska, S. (2007). 'Helicobacter pylori seroprevalence in coronary artery disease', Biochemia Medica, 17(2), str. 193-196. Preuzeto s: https://hrcak.srce.hr/18134 (Datum pristupa: 27.01.2021.)
Vancouver
Grozdovska-Naumoska M, Kotevski V, Trojacanec-Piponska S. Helicobacter pylori seroprevalence in coronary artery disease. Biochemia Medica [Internet]. 2007 [pristupljeno 27.01.2021.];17(2):193-196. Dostupno na: https://hrcak.srce.hr/18134
IEEE
M. Grozdovska-Naumoska, V. Kotevski i S. Trojacanec-Piponska, "Helicobacter pylori seroprevalence in coronary artery disease", Biochemia Medica, vol.17, br. 2, str. 193-196, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/18134. [Citirano: 27.01.2021.]
Puni tekst: hrvatski, pdf (119 KB) str. 193-196 preuzimanja: 429* citiraj
APA 6th Edition
Grozdovska-Naumoska, M., Kotevski, V. i Trojacanec-Piponska, S. (2007). Seroprevalencija infekcije Helicobacter pylori u koronarnoj arterijskoj bolesti. Biochemia Medica, 17 (2), 193-196. Preuzeto s https://hrcak.srce.hr/18134
MLA 8th Edition
Grozdovska-Naumoska, Mirjana, et al. "Seroprevalencija infekcije Helicobacter pylori u koronarnoj arterijskoj bolesti." Biochemia Medica, vol. 17, br. 2, 2007, str. 193-196. https://hrcak.srce.hr/18134. Citirano 27.01.2021.
Chicago 17th Edition
Grozdovska-Naumoska, Mirjana, Vlatko Kotevski i Sonja Trojacanec-Piponska. "Seroprevalencija infekcije Helicobacter pylori u koronarnoj arterijskoj bolesti." Biochemia Medica 17, br. 2 (2007): 193-196. https://hrcak.srce.hr/18134
Harvard
Grozdovska-Naumoska, M., Kotevski, V., i Trojacanec-Piponska, S. (2007). 'Seroprevalencija infekcije Helicobacter pylori u koronarnoj arterijskoj bolesti', Biochemia Medica, 17(2), str. 193-196. Preuzeto s: https://hrcak.srce.hr/18134 (Datum pristupa: 27.01.2021.)
Vancouver
Grozdovska-Naumoska M, Kotevski V, Trojacanec-Piponska S. Seroprevalencija infekcije Helicobacter pylori u koronarnoj arterijskoj bolesti. Biochemia Medica [Internet]. 2007 [pristupljeno 27.01.2021.];17(2):193-196. Dostupno na: https://hrcak.srce.hr/18134
IEEE
M. Grozdovska-Naumoska, V. Kotevski i S. Trojacanec-Piponska, "Seroprevalencija infekcije Helicobacter pylori u koronarnoj arterijskoj bolesti", Biochemia Medica, vol.17, br. 2, str. 193-196, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/18134. [Citirano: 27.01.2021.]

Sažetak
Background: Helicobacter (H.) pylori infection is a well-established cause of chronic gastritis and peptic ulcer disease. However, there is growing evidence that chronic inflammatory response to this pathogen may also play an important role in coronary artery disease (CAD). The aim of this study was to investigate the difference in seroprevalence of H. pylori infection in a control group compared to a group of patients with electrocardiographic evidence of CAD.
Materials and Methods: The study included 98 apparently healthy control subjects as the control group and 102 heart disease patients with electrocardiographic evidence of CAD as the patient group. Quantitative measurement of IgG antibodies to H. pylori in sera from subjects of both groups was performed with an automated commercial EIA method.
Results: Seroprevalence of H. pylori IgG was significantly higher in the patient group (87.3%) compared to the control group (54.1%) (P<0.001).
Conclusion: The results suggest that there may be an increased seroepidemiological association of H. pylori infection with CAD.

Ključne riječi
Helicobacter pylori; coronary artery disease; inflammation

Hrčak ID: 18134

URI
https://hrcak.srce.hr/18134

[hrvatski]

Posjeta: 1.334 *